Activation of peroxisome proliferator-activated receptor gamma in mammary epithelial cells upregulates the expression of tumor suppressor Cyld to mediate growth inhibition and anti-inflammatory effects
- 1 January 2017
- journal article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 82, 49-56
Abstract
No abstract availableKeywords
Funding Information
- European Union
- Greek national funds
This publication has 29 references indexed in Scilit:
- Clinical significance of CYLD downregulation in breast cancerBreast Cancer Research and Treatment, 2014
- SIRT1 is regulated by a PPARγ–SIRT1 negative feedback loop associated with senescenceNucleic Acids Research, 2010
- Troglitazone inhibits histone deacetylase activity in breast cancer cellsCancer Letters, 2010
- APC-dependent suppression of colon carcinogenesis by PPARγProceedings of the National Academy of Sciences, 2002
- Novel Therapeutic Approach: Ligands for PPARγ and Retinoid Receptors Induce Apoptosis in bcl-2-positive Human Breast Cancer CellsBreast Cancer Research and Treatment, 2002
- The Mechanisms of Action of PPARsAnnual Review of Medicine, 2002
- Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cellsNature, 2001
- Identification of the familial cylindromatosis tumour-suppressor geneNature Genetics, 2000
- Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX miceProceedings of the National Academy of Sciences, 1998
- Ultraspiracle, a Drosophila Retinoic X Receptor α Homologue, Can Mobilize the Human Thyroid Hormone Receptor To Transactivate a Human PromoterBiochemistry, 1997